viloxazine has been researched along with Obesity in 1 studies
Viloxazine: A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirby, MJ | 1 |
| Pleece, SA | 1 |
| Redfern, PH | 1 |
1 other study available for viloxazine and Obesity
| Article | Year |
|---|---|
The effect of viloxazine hydrochloride (Vivalan) on food intake and obesity in the rat [proceedings].
Topics: Animals; Body Weight; Feeding Behavior; Female; Morpholines; Obesity; Rats; Viloxazine | 1978 |